UBS O'Connor’s Merck MRK Stock Holding History

UBS O'Connor’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,790	Closed	-$596K	–	571
2023 Q3	$596K	Hold	5,790	–	–	0.01%	387
2023 Q2	$668K	Sell	5,790 -12,074	-68%	-$1.37M	0.01%	423
2023 Q1	$1.9M	Buy	+17,864	New	+$1.93M	0.05%	327
2022 Q4	–	Sell	-22,800	Closed	-$1.96M	–	196
2022 Q3	$1.96M	Buy	+22,800	New	+$2.04M	0.02%	627
2017 Q3	–	Sell	-44,280	Closed	-$2.71M	–	405
2017 Q2	$2.71M	Buy	+44,280	New	+$2.7M	0.04%	234
2013 Q3	–	Sell	-109,097	Closed	-$4.83M	–	520
2013 Q2	$4.83M	Buy	+109,097	New	+$4.87M	0.09%	243

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS O'Connor's MRK Position: Q4 2023 in Review

UBS O'Connor sold out of Merck (MRK) in Q4 2023, closing a stake of 5,790 shares — an estimated $596K sold.

UBS O'Connor first reported a position in MRK in Q2 2013 and held it in 6 quarters. The position peaked at $4.83M in Q2 2013. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

UBS O'Connor reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
UBS O'Connor sold 5,790 Merck shares in Q4 2023, an estimated $596K.
UBS O'Connor first reported a position in Merck in Q2 2013 and held it in 6 quarters.
UBS O'Connor's Merck position peaked at $4.83M in Q2 2013.
3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.